Modifying Oncolytic Adenoviruses to Target Pancreatic Cancer
Pancreatic cancer is one of the less common but deadliest cancers. Modified oncolytic adenoviruses represent an alternative to chemotherapy and targeted therapies, which have a high mortality rate.